Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs

Accumulation of EBI3 induced by virulent Mycobacterium tuberculosis inhibits apoptosis in murine macrophages

(2019) Jia-Hui Deng et al.   Pathogens and Disease

High-throughput Screening and Identification of Potent Broad-spectrum Inhibitors of Coronaviruses

(2019) Liang Shen et al.   JOURNAL OF VIROLOGY

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid

(2019) David H. Salinger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis

(2018) Sunil Kumar et al.   TUBERCULOSIS

Molecular epidemiology and drug resistance patterns of Mycobacterium tuberculosis complex isolates from university students and the local community in Eastern Ethiopia

(2018) Abiyu Mekonnen et al.   PLoS One

History of Pulmonary Tuberculosis

(2018) A. Thomas Pezzella   Thoracic Surgery Clinics

Selection and identification of specific glycoproteins and glycan biomarkers of macrophages involved in Mycobacterium tuberculosis infection

(2017) Xiao-Lei Tang et al.   TUBERCULOSIS

WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells

(2016) LIANG XU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Delamanid in the treatment of multidrug-resistant tuberculosis

(2016) R. Gupta et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs

(2014) Liwei An et al.   ANTIVIRAL RESEARCH

Drug resistance and tuberculosis elimination in low-incidence countries: Figure 1–

(2014) Dennis Falzon et al.   EUROPEAN RESPIRATORY JOURNAL

The impact of pyrvinium pamoate on colon cancer cell viability

(2014) Armin Wiegering et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Mycobacterium tuberculosis Treatment Modalities and Recent Insights

(2014) V. Sukhithasri et al.   Current Drug Delivery

Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system

(2013) Jason Lamontagne et al.   ANTIVIRAL RESEARCH

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication

(2013) Koen W.R. van Cleef et al.   ANTIVIRAL RESEARCH

An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs

(2013) Lili Mao et al.   PLoS One

The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer

(2013) Wei Xu et al.   PLoS One

New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing

(2012) F. Imperi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments

(2012) Eriko Tomitsuka et al.   JOURNAL OF BIOCHEMISTRY

Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration

(2012) Isao Ishii et al.   Frontiers in Oncology

Identification of BPR3P0128 as an Inhibitor of Cap-Snatching Activities of Influenza Virus

(2011) John T.-A. Hsu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The NADH-fumarate reductase system, a novel mitochondrial energy metabolism, is a new target for anticancer therapy in tumor microenvironments

(2010) Eriko Tomitsuka et al.   Annals of the New York Academy of Sciences

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α

(2010) Curtis A Thorne et al.   Nature Chemical Biology

Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors

(2010) Mudassar Altaf et al.   TUBERCULOSIS

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection

(2009) P. Gastaminza et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New anti-tuberculosis agents amongst known drugs

(2009) Kathryn E.A. Lougheed et al.   TUBERCULOSIS